BOLD (Boundless Bio, Inc.) Stock Financials & Earnings | Market Cap Arena

BOLD (Boundless Bio, Inc.) Stock Financials & Earnings | Market Cap Arena

BOLDBoundless Bio, Inc.

Mkt Cap$26M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Revenue (TTM)$0

Net Income (TTM)-$58M

EPS (TTM)-$2.60

Free Cash Flow (TTM)-$47M

Gross Margin—

Op. Margin—

Net Margin—

FCF Margin—

P/S Ratio (TTM)—

P/E Ratio (TTM)—

YoY Rev Growth—

Employees—

Earnings Reports

Next: Q1 2026 · Mar 26

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$0	$0	-$12M
Q2 23	$0	$0	-$14M
Q3 23	$0	$0	-$15M
Q4 23	$0	$0	-$14M
Q1 24	$0	$0	-$17M
Q2 24	$0	-$265K	-$19M
Q3 24	$0	$0	-$19M
Q4 24	$0	$0	-$18M
Q1 25	$0	$0	-$17M
Q2 25	$0	-$317K	-$17M
Q3 25	$0	-$310K	-$15M
Q4 25	$0	$0	-$14M

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 23	-$12M	-$12M
Q2 23	-$11M	-$11M
Q3 23	-$12M	-$12M
Q4 23	-$12M	-$12M
Q1 24	-$16M	-$16M
Q2 24	-$16M	-$18M
Q3 24	-$13M	-$14M
Q4 24	-$16M	-$16M
Q1 25	-$15M	-$15M
Q2 25	-$12M	-$12M
Q3 25	-$10M	-$10M
Q4 25	-$10M	-$11M

Capital Expenditures

CapEx

Quarter	CapEx
Q1 23	$86K
Q2 23	$128K
Q3 23	$151K
Q4 23	$268K
Q1 24	$83K
Q2 24	$2M
Q3 24	$483K
Q4 24	$466K
Q1 25	$59K
Q2 25	$48K
Q3 25	$15K
Q4 25	$424K

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 23	—	-87.8%
Q2 23	—	-90.5%
Q3 23	—	+12.8%
Q4 23	—	+14.3%
Q1 24	—	+39.7%
Q2 24	—	+38.9%
Q3 24	—	+25.2%
Q4 24	—	+32.5%
Q1 25	—	+2.7%
Q2 25	—	-12.0%
Q3 25	—	-19.1%
Q4 25	—	-23.4%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 23	$615K	—
Q2 23	$927K	—
Q3 23	$883K	—
Q4 23	$911K	—
Q1 24	$1M	—
Q2 24	$2M	—
Q3 24	$2M	—
Q4 24	$2M	—
Q1 25	$2M	—
Q2 25	$2M	—
Q3 25	$1M	—
Q4 25	$1M	—

OpEx Breakdown

Quarter	R&D	G&A
Q1 23	$10M	$3M
Q2 23	$11M	$3M
Q3 23	$12M	$3M
Q4 23	$10M	$3M
Q1 24	$13M	$4M
Q2 24	$14M	$5M
Q3 24	$14M	$5M
Q4 24	$13M	$5M
Q1 25	$12M	$5M
Q2 25	$12M	$5M
Q3 25	$10M	$4M
Q4 25	$10M	$4M

War Chest

Quarter	Cash	Short-term Investments	Total
Q4 22	$11M	$56M	$67M
Q2 23	$41M	$103M	$144M
Q3 23	$21M	$112M	$133M
Q4 23	$24M	$97M	$121M
Q1 24	$25M	$80M	$105M
Q2 24	$31M	$148M	$179M
Q3 24	$40M	$127M	$167M
Q4 24	$27M	$126M	$152M
Q1 25	$15M	$123M	$138M
Q2 25	$15M	$112M	$127M
Q3 25	$15M	$103M	$118M
Q4 25	$18M	$90M	$108M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q1 23	22M	+0.0%
Q2 23	22M	+0.0%
Q3 23	22M	+0.0%
Q4 23	22M	+0.0%
Q1 24	22M	+0.0%
Q2 24	22M	-1.0%
Q3 24	22M	+1.0%
Q4 24	17M	-23.7%
Q1 25	22M	+31.3%
Q2 25	22M	+0.3%
Q3 25	22M	+0.1%
Q4 25	22M	-0.1%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 16	—	—
FY 17	—	—
FY 18	—	—
FY 21	—	—
FY 22	—	—
FY 23	—	—
FY 24	$0	200K
FY 25	$0	200K